Peking University Cancer Hospital
Beijing, Beijing Municipality, 100142, China
NCT Number: NCT03247478
This is a prospective, single-center, non-randomized, non-controlled observational study.
Looking for future studies?
Notify MeFemale
Observational
Beijing, Beijing Municipality, 100142, China
The negative predictive value of ultrasound for lymph node with neoadjuvant chemotherapy is low, magnetic resonance imaging (MRI) or PET/CT did not significantly improve specificity to axillary lymph node. The aim of this study is to determine performance of computed tomography (CT) reconstruction on evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: within 6 weeks after obtaining the post-surgery pathological results
Sensitivity, specificity, positive-predictive value (PPV) and negative-predictive value (NPV) of Computed tomography (CT) reconstruction for axillary lymph node status after neoadjuvant chemotherapy will be assessed.
Time frame: within 6 weeks after obtaining the post-surgery pathological results
The diagnostic performance of computed tomography (CT) reconstruction for the evaluation of ALN after NAC was evaluated with receiver operating characteristic (ROC) curve analysis. The diagnostic accuracy was estimated by calculating the area under the ROC curve.
Peking University
Other
Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure: a Prospective Observational Study Evaluating Response in Axillary Lymph Nodes of Breast Cancer After Neoadjuvant Chemotherapy
Acronym: CTREP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01340495
Breast Diseases, Breast Neoplasms
Boston, Massachusetts, United States
View Trial DetailsNCT03387553
Breast Cancer, Breast Cancer Female
Tampa, Florida, United States
View Trial DetailsNCT04245176
Breast Cancer, Breast Carcinoma In Situ
Boston, Massachusetts, United States
View Trial DetailsNCT03212170
Breast Diseases, Breast Neoplasms
Madison, Wisconsin, United States
View Trial Details